NCT04327661

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Motion Syros: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness During Travel

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 366 (actual)
• Sponsor: Vanda Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in subjects affected by motion sickness during travel

Conditions

• Motion Sickness

Interventions

Type	Name	Description
DRUG	Tradipitant	Oral Capsule
DRUG	Placebo	Oral Capsule

Timeline

• Start date: 2021-11-15
• Primary completion: 2023-04-01
• Completion: 2023-04-12
• First posted: 2020-03-31
• Last updated: 2024-12-11
• Results posted: 2024-12-11

Locations

7 sites across 1 country: United States

Regulatory

• FDA-regulated drug study